02/28/2025
3:02 PM | Intellia Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2025
3:17 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:41 PM | Intellia Therapeutics (Issuer)
Schultes Birgit C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/10/2025
6:30 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
10:29 AM | Intellia Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/07/2025
4:20 PM | Hicks Derek (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:20 PM | Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:22 PM | BASTA JAMES (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:23 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for NTLA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Intellia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/07/2024
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
3:59 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:29 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
3:17 PM | Dulac Edward J III (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:13 PM | Dulac Edward J III (Reporting)
Intellia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
3:03 PM | Intellia Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/03/2024
12:15 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
12:15 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
7:06 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
4:00 PM | Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:14 PM | Goff Brian (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:15 PM | Goff Brian (Reporting)
Intellia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/14/2024
3:16 PM | CHASE WILLIAM J (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:18 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:19 PM | Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:21 PM | Intellia Therapeutics (Issuer)
Keresty Georgia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:22 PM | Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:25 PM | Intellia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:40 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:16 PM | Intellia Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:10 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/15/2024
3:21 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
8:26 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free NTLA Stock Alerts